Related Experiment Videos
Urinary growth hormone and insulin-like growth factor I. Effects of growth-hormone injection schedule
C H Albini1, T Quattrin, B Mills
1Department of Pediatrics, Children's Hospital of Buffalo, NY 14222.
Insights
Urinary growth hormone (GH) and insulin-like growth factor I (IGF-I) excretion in children depend on GH administration frequency. Daily GH injections lead to higher urinary GH and IGF-I levels compared to less frequent dosing.
Area of Science:
- Pediatric Endocrinology
- Biochemistry
- Pharmacokinetics
Background:
- Biosynthetic growth hormone (GH) therapy is crucial for treating growth disorders in children.
- Understanding the excretion profiles of GH and insulin-like growth factor I (IGF-I) is essential for optimizing treatment efficacy.
- Urinary markers may offer a non-invasive method to assess GH/IGF-I dynamics.
Purpose of the Study:
- To compare urinary GH and IGF-I excretion patterns in children receiving biosynthetic GH with different administration frequencies.
- To evaluate the impact of daily versus thrice-weekly GH injections on urinary GH and IGF-I levels.
Main Methods:
- A comparative study involving three groups of children: healthy controls, thrice-weekly GH recipients, and daily GH recipients.
- Overnight urine samples were collected for three consecutive nights from all participants.
- Urinary GH and IGF-I concentrations were measured and analyzed based on administration frequency.
Main Results:
- Children receiving daily GH injections showed significantly higher urinary GH output throughout the study compared to controls and those receiving GH thrice-weekly.
- Urinary GH output in the thrice-weekly group was higher on the first day post-injection, decreasing on subsequent days.
- Urinary IGF-I output was significantly lower on day three in the thrice-weekly group compared to both controls and the daily GH group.
Conclusions:
- The frequency of biosynthetic GH administration significantly influences urinary GH and IGF-I excretion profiles in children.
- Daily GH administration appears to maintain more consistent and elevated levels of urinary GH and IGF-I.
- Urinary GH and IGF-I excretion patterns can serve as indicators of GH treatment response and dosing regimen effectiveness.
Abstract:
Urinary growth hormone (GH) and insulin-like growth factor I (IGF-I) excretion profiles were compared in children receiving biosynthetic GH. Group 1 included 18 healthy controls. Group 2 included nine children given biosynthetic GH three times a week. Group 3 included 14 children given daily GH injections. Overnight urine samples were collected for three consecutive nights in all groups. No significant day-to-day variation in urinary GH output was observed in group 1. In group 2, urinary GH output was significantly higher on day one following injection than on days two and three. Urine GH outputs in group 2 were significantly lower on days two and three than the values observed on all days in group 3. Throughout the three-day study, subjects in group 3 excreted similar amounts of GH significantly higher than those of controls. Urinary IGF-I output (nmol/kg) was similar on all three study days in groups 1 and 3. Group 2 had significantly lower urinary IGF-I output on day three compared with day one. Urinary IGF-I output on day three was also significantly lower in group 2 than in group 3. We conclude that urinary GH and IGF-I outputs are influenced by the frequency of GH administration.